Eli Lilly announced it will acquire Ajax Therapeutics to further advance treatment results for patients with myelofibrosis and polycythemia vera through this merger.

老虎证券2026/04/27 10:51

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This strategic acquisition aims to strengthen Eli Lilly's R&D pipeline in the field of hematological diseases and provide more effective treatment options for patients with these two rare blood disorders. After the merger is completed, Eli Lilly will integrate Ajax Therapeutics' innovative technology platform to accelerate the clinical development of related therapies.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Eli Lilly announced it will acquire Ajax Therapeutics to further advance treatment results for patients with myelofibrosis and polycythemia vera through this merger.

You may also like

Crypto prices